Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Transcutaneous VNS on the ear shows positive effects in lupus pilot trial
Promising improvements in musculoskeletal pain, fatigue, and swollen and tender joints were reported with stimulation.
News
Lower TNF inhibitor efficacy observed in women with nonradiographic axSpA
Findings are similar to those reported for sex differences in TNF inhibitor response seen in radiographic disease.
News
New lupus classification criteria perform well in children, young adults
A new study upholds the accuracy of the 2019 ACR-EULAR classification criteria in patients aged 21 years and younger.
News
Golimumab approval extended to polyarticular-course JIA and juvenile PsA
The expanded approval to include pediatric indications came as part of a review of a clinical trial mandated by the Pediatric Research Equity Act...
News
FDA adds polyarticular-course JIA to approved indications for tofacitinib
The approval is the fourth indication in the United States for tofacitinib after approvals for treatment of adults with rheumatoid arthritis,...
News
High disability after a year of RA treatment signals increased mortality risk
The findings from the Canadian Early Arthritis Cohort may serve to guide physician-patient discussions.
News
RA patients show decreased risk for new-onset type 2 diabetes
Treatment with biologic disease-modifying antirheumatic drugs is a likely contributor to the lower risk for type 2 diabetes mellitus.
News
Rheumatologist Lindsey Criswell named new NIAMS director
Dr. Criswell will start her new position in early 2021.
News
FDA approves Tremfya (guselkumab) for psoriatic arthritis
The FDA’s approval marks the second indication for guselkumab, which was first approved for adults with plaque psoriasis in 2017.
News
ACR to hold all-virtual annual meeting in November
The event, dubbed ACR Convergence 2020, will take place Nov. 5-9, 2020.
News
Unacceptable RA pain may drop with TNFi treatment but still lingers in many patients
These results lend “some support to a better effect on long-term pain for the biological treatment, compared with triple therapy, [but also show]...
News
EULAR cancels June congress, will hold virtual meeting instead
The details of the virtual congress experience have yet to be worked out.
News
Rheumatologists seek to reassure amid hydroxychloroquine shortage
Rheumatologists Jill P. Buyon and Peter M. Izmirly answer questions about the availability of hydroxychloroquine during the COVID-19 pandemic, and...
News
ACR cancels March conference, symposium
The American College of Rheumatology has canceled its Division & Program Directors Conference and State-of-the-Art Clinical Symposium.
News
Use of mHealth technology lags in lupus care, research
A systematic review finds that “most apps scored poorly based on design, user interface, functionality, and credibility,” as well as a dearth of...